Bone marrow progenitor cell therapy-mediated paracrine regulation of cardiac miRNA-155 modulates fibrotic response in diabetic hearts - Wikidata - wikimedia - TriplyDB

Bone marrow progenitor cell therapy-mediated paracrine regulation of cardiac miRNA-155 modulates fibrotic response in diabetic hearts

Bone marrow progenitor cell therapy-mediated paracrine regulation of cardiac miRNA-155 modulates fibrotic response in diabetic hearts

http://www.wikidata.org/entity/Q34656322

about

Cardiac regeneration and diabetes Bone Marrow-Derived Stem Cells: a Mixed Blessing in the Multifaceted World of Diabetic Complications Cell Therapy in Patients with Critical Limb Ischemia The Role of MicroRNAs in Diabetic Complications-Special Emphasis on Wound Healing Non-Coding RNAs Including miRNAs and lncRNAs in Cardiovascular Biology and Disease The Emerging Role of MicroRNA-155 in Cardiovascular Diseases MiR-155 Knockout in Fibroblasts Improves Cardiac Remodeling by Targeting Tumor Protein p53-Inducible Nuclear Protein 1 Bone marrow mesenchymal stem cell-derived vascular endothelial growth factor attenuates cardiac apoptosis via regulation of cardiac miRNA-23a and miRNA-92a in a rat model of myocardial infarction Altered ECM deposition by diabetic foot ulcer-derived fibroblasts implicates fibronectin in chronic wound repair.Small engine, big power: microRNAs as regulators of cardiac diseases and regeneration.Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction.Enhancer-associated long noncoding RNAs: A novel frontier with new perception in cardiac regeneration.Targeting miR-155 to Treat Experimental Scleroderma MicroRNA: A new therapeutic strategy for cardiovascular diseases.Paracrine Effects of Adipose-Derived Stem Cells on Matrix Stiffness-Induced Cardiac Myofibroblast Differentiation via Angiotensin II Type 1 Receptor and Smad7 Cell therapy in Brazil: time for reflection.Reoxygenation-derived toxic reactive oxygen/nitrogen species modulate the contribution of bone marrow progenitor cells to remodeling after myocardial infarction.Interaction between myofibroblasts and stem cells in the fibrotic heart: balancing between deterioration and regeneration.Concise review: Mechanotransduction via p190RhoGAP regulates a switch between cardiomyogenic and endothelial lineages in adult cardiac progenitors.SnoN as a novel negative regulator of TGF-β/Smad signaling: a target for tailoring organ fibrosis.A comparison of gene expression profiles in patients with coronary artery disease, type 2 diabetes, and their coexisting conditions.Improving stem cell therapy in cardiovascular diseases: the potential role of microRNA.Stem cells and diabetic cardiomyopathy: from pathology to therapy.Epigenetics in Reactive and Reparative Cardiac Fibrogenesis: The Promise of Epigenetic Therapy.Novel Anti-fibrotic Therapies.MicroRNA-155 aggravates ischemia-reperfusion injury by modulation of inflammatory cell recruitment and the respiratory oxidative burst.A brief review: the therapeutic potential of bone marrow mesenchymal stem cells in myocardial infarction.Notch activation enhances lineage commitment and protective signaling in cardiac progenitor cells.Interleukin-10 Deficiency Impairs Reparative Properties of Bone Marrow-Derived Endothelial Progenitor Cell Exosomes.Deciphering Non-coding RNAs in Cardiovascular Health and Disease.

P2860

Q21195758-F47EEAF3-B84D-47AF-A2AC-BFF4EE02A0D6 Q26749552-458BEEFB-A535-41AC-81E8-397C78FC5BC7 Q26795443-FEF3F259-BDB2-42F9-8827-1777F89C46AB Q26827627-549089C4-4089-4178-9748-E0DEE7CF3BE4 Q26999363-4D1090A3-2CD9-471E-988C-326A36A0CBD6 Q28072949-191B7D1B-36B7-4689-9BF7-8A4DC07BD2A8 Q28505621-FFF2E54B-98F2-4DB4-BAAF-5B38800B1F81 Q33853277-7B285C07-626F-41ED-9C2D-4413576F912E Q33881787-5D9CFE1E-DE42-4DA0-8AC3-C2F67B2E9668 Q34358827-F8FED3F4-AA76-4263-A7C0-F335175DBA8C Q35786316-C61B2948-5427-461A-A570-6BF75DF2A07B Q35988769-AE845CF9-AB1C-491B-AFD8-B793D70AA7B6 Q36524910-37EF80FC-A1D8-4A0B-B111-730CD82F96B7 Q37017196-3C08A749-5E11-48FF-AC81-46E3E7C20821 Q37310715-1184A0D4-FABA-40C6-A24E-4779493B6AAE Q37320694-3DCA16F2-F48C-4C50-AFE4-48362C711600 Q37648491-CFF51B93-EBBB-4F31-85B5-6612599BB3B1 Q38191761-A7239DA1-40BC-45B1-9D6F-BD872AF8D3CB Q38202900-F7737A17-3EA9-4244-AA83-9FFD16747039 Q38266174-76904D07-1EA5-4D30-9061-F89A502F9024 Q38735806-08B078E8-8DCA-4000-A7AD-48D495829CF3 Q38840533-111E4679-65C0-4327-A969-02F57E35BAC9 Q38843402-AA1335B8-5F90-416B-ACD7-2D56C60EC3E9 Q39018712-F01E770C-546A-4E34-A90E-8F8704880447 Q39377055-3E22B45C-ACB4-4976-A481-96352B9814DB Q46736926-B4E389E8-51DF-4CA7-95A9-6D3924C48171 Q47137130-05EB00BF-7256-4CD0-8423-F8190A7A6498 Q47713030-B8A3CCF5-CFD7-4142-9E0C-1D3A0A5C85E9 Q51020909-63EDDC37-885B-43FB-82EE-E59FC2C96F94 Q55668859-ED58161A-48CE-456B-AD25-FFCDD4B6CD26

P2860

Bone marrow progenitor cell therapy-mediated paracrine regulation of cardiac miRNA-155 modulates fibrotic response in diabetic hearts

http://www.wikidata.org/entity/Q34656322

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Bone marrow progenitor cell th ...... ic response in diabetic hearts

@ast

Bone marrow progenitor cell th ...... ic response in diabetic hearts

@en

Bone marrow progenitor cell th ...... ic response in diabetic hearts

@nl

type

label

Bone marrow progenitor cell th ...... ic response in diabetic hearts

@ast

Bone marrow progenitor cell th ...... ic response in diabetic hearts

@en

Bone marrow progenitor cell th ...... ic response in diabetic hearts

@nl

prefLabel

Bone marrow progenitor cell th ...... ic response in diabetic hearts

@ast

Bone marrow progenitor cell th ...... ic response in diabetic hearts

@en

Bone marrow progenitor cell th ...... ic response in diabetic hearts

@nl

P1433

Q34656322-E9A40104-85A0-429E-9A60-EC3FC7D560CA

P1476

Q34656322-E193724A-776A-4E5A-BAEA-973AC1444149

P2093

Q34656322-0CD73194-3D73-40FF-8747-822066E233A7

Q34656322-0DE57443-BDF2-40FC-93A8-D25461F9608C

Q34656322-21EF7890-9668-48F3-870A-0C9CCA3BEA75

Q34656322-63DA18B4-0D00-466A-BEF4-D1923ECA7367

Q34656322-91EC5D15-EF0B-4DCF-9BF4-6F359BD8F70C

Q34656322-EAA91F3F-75CD-4CAD-84FE-7A12C58B321F

Q34656322-FC0D7E59-EEE5-48B7-A5D2-26A97812798C

P2860

Q34656322-097362D9-11C5-46E7-BC1D-6241783119AF

Q34656322-09C7F56E-5F1A-48AD-948F-1EAEA2F6008A

Q34656322-0B2139C7-2A08-4236-8B7E-7477931FCA1A

Q34656322-0BCE198A-BDED-40E6-A487-972A8D7D93F5

Q34656322-0D2D7B86-C503-4F01-A7BD-1AAB60436D96

Q34656322-11D6A30A-F49F-4A18-955A-A2BAD1128C4D

Q34656322-179AC781-F0DD-4BE6-8C83-3D18C7BDD616

Q34656322-1A23DACA-A78E-4688-BF2D-7FA903971A13

Q34656322-1B78FE15-7969-406A-806E-D9F13B77F603

Q34656322-1C67F3C6-5B33-4CC7-8464-6D09DB0921AC

P304

Q34656322-59169BC8-9523-4B56-B227-1798C82CC892

P31

Q34656322-093E4245-CFED-45D5-9350-0F294ACADA81

P356

Q34656322-1EA7DAE0-26EE-4937-BCF9-A830BD203AAD

P407

Q34656322-8090B5F7-0278-468B-A5C6-5BE67A48203E

P433

Q34656322-BD85C21E-6DD2-4CBA-A581-7747AFD32168

P478

Q34656322-6AA5110C-EBA2-4E18-894D-650369C741F6

P577

Q34656322-7C73AB12-9676-46E6-A05A-506E26AA8C80

P5875

Q34656322-0265B644-98E3-4341-9D6E-AC0F40882E69

P698

Q34656322-F6557141-099B-4DAE-BCDF-F7776E341D88

P921

Q34656322-C61C0BC6-8D19-4788-87DD-BE09FE87000C

P932

Q34656322-12FC9545-6015-4EA5-A5CD-4BB153BAE697

P356

JOURNAL.PONE.0060161

P1433

P1476

Bone marrow progenitor cell th ...... ic response in diabetic hearts

@en

P2093

Alexander R Mackie

http://www.w3.org/2001/XMLSchema#string

Erin E Vaughan

http://www.w3.org/2001/XMLSchema#string

Ito Aiko

http://www.w3.org/2001/XMLSchema#string

Prasanna Krishnamurthy

http://www.w3.org/2001/XMLSchema#string

Raj Kishore

http://www.w3.org/2001/XMLSchema#string

Suresh K Verma

http://www.w3.org/2001/XMLSchema#string

Tatiana V Abramova

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium

MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue

MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA

MicroRNA-155 is induced during the macrophage inflammatory response

Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)

miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

Rac1 and RhoA differentially regulate angiotensinogen gene expression in stretched cardiac fibroblasts

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

P304

e60161

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0060161

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236115303

http://www.w3.org/2001/XMLSchema#string

P698

23560074

http://www.w3.org/2001/XMLSchema#string

P921

P932

3613379

http://www.w3.org/2001/XMLSchema#string